Skip to content
Screener

Evolent Health, Inc. EVH Q2 2026 earnings

Reported August 6, 2026 · Before market open

Revenue$652.5MBeat by $54.8M
EPS$0.02Beat by $0.03
Revenue estimate$597.7M
EPS estimate-$0.01
“We believe our results for the second quarter of 2026, our updated 2026 guidance and our 2027 outlook all demonstrate that Evolent is delivering strong growth, profitability and cash flow. We are confident in our emerging AI-led operational model that we believe allows us to deliver excellent client and clinical outcomes, while being highly disciplined with our cost structure.”
Seth Blackley

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$728.6M
EPS estimate$0.06

Financials

Q2 2026

Income statement

See full
Revenue$652.5M+46.9%
Gross profit$80.8M-19.5%
Operating income-$9.6M-716%
Net income-$28.4M-42.6%
EPS (diluted)-$0.25+43.2%

Balance sheet

See full
Cash & equivalents$115.7M-23.4%
Total debt$970.4M+13.7%
Total equity$383.2M-57.2%
Total assets$2.0B-19.9%

Cash flow

See full
Operating cash flow-$9.3M+69.3%

Valuation & ratios

Valuation

as of 09/16/26
See full
Market cap$422.84M-57.8%
Enterprise value$1.28B-25.0%
P/S0.2×-0.3×

Profitability

See full
Gross margin17.2%+0.9pp
Operating margin-20.4%-22.4pp
Net margin-24.1%-35.8pp

Returns & leverage

See full
Return on equity-79%-99.2pp
Debt / equity2.5×+1.6×
Current ratio1.2×+0.2×

Segments

By product

See full
Performance Suite$484.5M+92.0%
Specialty Technology and Services Suite$78.2M-4.0%
Administrative Services$48.0M-14.1%
Cases$41.9M+7.0%

By segment

See full
Evolent Health Services Segment$652.5M+46.9%

FAQ

When did Evolent Health, Inc. report Q2 2026 earnings?
Evolent Health, Inc. (EVH) reported Q2 2026 earnings on August 6, 2026 before market open.
What were Evolent Health, Inc.'s Q2 2026 revenue and EPS?
Evolent Health, Inc. reported revenue of $652.5M and eps of $0.02 for Q2 2026.
Did Evolent Health, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $597.7M by $54.8M. EPS beat the consensus estimate of $-0.01 by $0.03.
How did Evolent Health, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 46.9% from $444.3M a year earlier.
Where can I find Evolent Health, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628908-26-000084) and the 10-Q periodic report (0001628908-26-000086) directly on SEC EDGAR. The filing index links above go to sec.gov.